Treatment of children with Down syndrome and growth retardation with recombinant human growth hormone
- 30 September 1991
- journal article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 119 (3), 478-483
- https://doi.org/10.1016/s0022-3476(05)82068-2
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The Influence of Age on the 24-Hour Integrated Concentration of Growth Hormone in Normal Individuals*Journal of Clinical Endocrinology & Metabolism, 1985
- Effect of Clonidine Upon Anterior Pituitary Function and Plasma Catecholamine Concentrations in Short Children and AdolescentsJournal of Pediatric Endocrinology and Metabolism, 1985
- Growth Hormone Neurosecretory DysfunctionPublished by American Medical Association (AMA) ,1984
- Cholinergic Receptor Control Mechanisms for L-Dopa, Apomorphine, and Clonidine-Induced Growth Hormone Secretion in Man*Journal of Clinical Endocrinology & Metabolism, 1983
- Oral clonidine — an effective growth hormone-releasing agent in prepubertal subjectsThe Journal of Pediatrics, 1982
- A Dose-Response Curve for Human Growth HormoneJournal of Clinical Endocrinology & Metabolism, 1981
- Growth Hormone and other Responses to Clonidine in Patients with Endogenous DepressionThe British Journal of Psychiatry, 1981
- ORAL CLONIDINE AS A GROWTH HORMONE STIMULATION TESTThe Lancet, 1979
- Circadian Variation of Integrated Concentration of Growth Hormone in Children and AdultsJournal of Clinical Endocrinology & Metabolism, 1975
- Defective growth hormone secretion in primary microcephalyThe Journal of Pediatrics, 1974